An innovation being tested in Kisumu town shows that women may soon start using gels to prevent contracting HIV and other sexually transmitted diseases.
According to the Deputy Director of Kenya Medical Research Institute (Kemri) Prof Elizabeth Bukusi who is leading the innovation, the institution has already carried out all the clinical trials.
"We did all the clinical trials on 20 women who volunteered and were of between the age of 18 years and 24 years in Kisumu town," Bukusi said.
Bukusi who was speaking on Thursday at her office in Kisumu town told the press that the gel usually produces two types of antiretroviral for a specified period only.
"This is an advanced type of gel that is in a position to kill and even neutralise bacteria and viruses. If used properly, the gel is in a position to kill HIV and sometimes neutralise it hence preventing infection," Bukusi said.
Bukusi added that they have not finalised the research and some work remains to be done before they release the final results.
"We are not telling women to start using the gel now but we are at an advanced stage. In the meantime, women should continue using the protection methods they have been using," Bukusi said.